why choose us

First received: November 06, 2023

Clinical Trial: The Efficacy and Safety of Protoxin in Subjects With Moderate to Severe Glabellar Lines

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Glabellar Frown Lines

Study Type: INTERVENTIONAL


Official Title: A Multicenter, Single Group, Open, Extension Study of Phase III Clinical Trial to Compare the Efficacy and Safety of Protoxin in Subjects With Moderate to Severe Glabellar Lines

Brief Summary: This clinical trial is an extended clinical trial for test subjects who participated in the phase 3 clinical trial of PT_BTA_P3_21 (clinical trial plan number) and completed follow-up observation up to 16 weeks after administration of clinical trial drugs, and evaluates the effectiveness and safety of repeated administration of protoxin in those with moderate or severe brow wrinkles.

Read more